Acro Biomedical (ACBM) Enterprise Value (2015 - 2025)
Acro Biomedical's quarterly Enterprise Value came in at -$4098.0 in Q4 2025, down 760.92% year-on-year from $620.04 in Q4 2024, and up 5.2% quarter-over-quarter from -$4323.0 in Q3 2025.
Acro Biomedical has reported Enterprise Value for 11 years, with the latest figure at -$4098.0 in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 760.92% year-over-year to -$4098.0; the trailing twelve-month figure through Dec 2025 stood at -$4098.0 (down 760.92% YoY), and the FY2025 full-year result was -$4098.0, down 760.92% from the prior year.
- Enterprise Value for Q4 2025 stood at -$4098.0, up from -$4323.0 in the prior quarter.
- The five-year high for Enterprise Value was -$26.0 in Q2 2025, with the low at -$357668.0 in Q1 2022.
- Average Enterprise Value over 5 years is -$45593.5, with a median of -$5202.0 recorded in 2022.
- Year-over-year, Enterprise Value tumbled 99042.95% in 2021 and surged 98.73% in 2023.
- Tracing ACBM's Enterprise Value over 5 years: stood at -$95248.0 in 2021, then surged by 93.86% to -$5852.0 in 2022, then jumped by 93.57% to -$376.0 in 2023, then fell by 26.6% to -$476.0 in 2024, then sank by 760.92% to -$4098.0 in 2025.
- The last three Enterprise Value figures came in at -$4098.0 (Q4 2025), -$4323.0 (Q3 2025), and -$26.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -1.47 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -209,016.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | -28,828.00 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | -167,798.00 |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -1.00 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | -456,983.00 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | -521,352.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | -691,167.00 |
| 10 | Acro Biomedical | - | - | - | -4,098.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,098.00 |
| Sep 30, 2025 | -4,323.00 |
| Jun 30, 2025 | -26.00 |
| Mar 31, 2025 | -251.00 |
| Dec 31, 2024 | -476.00 |
| Sep 30, 2024 | -701.00 |
| Jun 30, 2024 | -926.00 |
| Mar 31, 2024 | -151.00 |
| Dec 31, 2023 | -376.00 |
| Sep 30, 2023 | -7,501.00 |
| Jun 30, 2023 | -6,910.00 |
| Mar 31, 2023 | -4,552.00 |
| Dec 31, 2022 | -5,852.00 |
| Sep 30, 2022 | -16,188.00 |
| Jun 30, 2022 | -12,107.00 |
| Mar 31, 2022 | -357,668.00 |
| Dec 31, 2021 | -95,248.00 |
| Sep 30, 2021 | -154,663.00 |
| Jun 30, 2021 | -215,494.00 |
| Mar 31, 2021 | -24,359.00 |
| Dec 30, 2020 | -18,123.00 |
| Sep 30, 2020 | -156.00 |
| Jun 30, 2020 | -381.00 |
| Mar 31, 2020 | -10,636.00 |
| Dec 31, 2019 | -911.00 |
| Sep 30, 2019 | -6,464.00 |
| Jun 30, 2019 | -5,223.00 |
| Mar 31, 2019 | -5,404.00 |
| Dec 31, 2018 | -42,599.00 |
| Sep 30, 2018 | -1,148.00 |
| Jun 30, 2018 | -4,615.00 |
| Mar 31, 2018 | -471,831.00 |
| Dec 31, 2017 | -8,542.00 |
| Sep 30, 2017 | -36,810.00 |
| Dec 31, 2016 | -2,391.00 |
| Sep 30, 2016 | -2,533.00 |
| Jun 30, 2016 | -2,141.00 |
| Mar 31, 2016 | -7,742.00 |
| Dec 31, 2015 | -15,907.00 |
| Sep 30, 2015 | -27,275.00 |